Affiliation:
1. Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt
2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt
3. Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in
Alexandria, Alexandria, Egypt
Abstract
Background:
Microbial L-asparaginase (L-ASNase, EC 3.5.1.1) is a pivotal biopharmaceutical
drug-protein that catalyzes the hydrolysis of the non-essential amino acid L-asparagine
(L-Asn) into L-aspartic acid (L-Asp) and ammonia , resulting in deplenishing the cellular L-Asn
pool, which leads to the ultimate death of the L-asparagine synthetase (L-ASNS) deficient cancerous
cells.
Objective:
This study aimed to investigate the impact of conjugating low molecular weight polyethylene
glycol to recombinant P. aeruginosa L-ASNase by examining the pharmacokinetic properties,
affinity towards the substrate, and enzyme stability prior to and following the reaction.
Methods:
The recombinant P. aeruginosa L-ASNase was affinity purified and then PEGylated
by attaching polyethylene glycol (MW= 330 Da) site-specifically to the protein's N-terminus
end. After which, the PEGylated L-ASNase was examined by SDS-PAGE (15%), FTIR, and
UV/Vis spectrophotometry and subsequently biochemically characterized.
Results:
The Km and Vmax values of free P. aeruginosa rL-ASNase were determined to be 0.318
±1.76 mM and 2915 μmol min-1and following the PEGylation, they were found to be 0.396 ±1.736
mM and 3193 μmol min-1, respectively. Polyethylene glycol (330 Da) has markedly enhanced LASNase
thermostability at 37, 45, 50, and 55 °C, as opposed to the free enzyme, which retained
19.5% after 1 h of incubation at 37 °C. The PEGylated L-ASNase was found to be stable upon
incubation with human serum for 28 h, in contrast to the sharp decline in the residual bioactivity of
the free rL-ASNase after 4 h incubation. Accordingly, an in vivo study was used for validation, and
it demonstrated that PEGylated rL-ASNase exhibited longer bioactivity for 24 h, while the free
form's activity vanished entirely from the rats' blood sera after 8 h. Molecular dynamics simulation
indicated that PEG (330 Da) has affected the hydrodynamic volume of L-ASNase and increased its
structural stability. Docking analysis has explored the position of PEG with respect to binding
sites and predicted a similar binding affinity to that of the free enzyme.
result:
: It was found that free P. aeruginosa rL-ASNase has Km and Vmax values of 0.318 ±1.76 mM and 2915 μmol min-1and after PEGylation the km and Vmax were found to be 0.396 ±1.736 mM and 3193 μmol min-1, respectively. PEG (330 Da) has greatly enhanced L-ASNase thermostability at 37, 45, 50 and 55 °C, compared to the free enzyme that retained only 19.5
Conclusion:
For the first time, recombinant L-ASNase was modified by covalently attaching
PEG (330 Da). The resultant novel proposed PEGylated rL-ASNase with remarkably increased
stability and prolonged in vivo half-life duration, which could be considered an alternative to
mitigate the high molecular weight of PEGylation's drawbacks.
Publisher
Bentham Science Publishers Ltd.